A single-dose study found that when
raloxifene was given with
warfarin the
pharmacokinetics of both drugs were not altered.
Despite the lack of pharmacokinetic interaction, modest decreases in prothrombin times have been seen, which may develop over several weeks. The manufacturers therefore recommend that prothrombin times should be checked. They extend this recommendation to cover the use of all coumarins.